Lemonade Earnings Calls
| Release date | Apr 29, 2026 |
| EPS estimate | -$0.580 |
| EPS actual | -$0.470 |
| EPS Surprise | 18.97% |
| Revenue estimate | 251.51M |
| Revenue actual | 258M |
| Revenue Surprise | 2.58% |
| Release date | Feb 19, 2026 |
| EPS estimate | -$0.410 |
| EPS actual | -$0.290 |
| EPS Surprise | 29.27% |
| Revenue estimate | 217.895M |
| Revenue actual | 228.1M |
| Revenue Surprise | 4.68% |
| Release date | Nov 05, 2025 |
| EPS estimate | -$0.720 |
| EPS actual | -$0.510 |
| EPS Surprise | 29.17% |
| Revenue estimate | 218.067M |
| Revenue actual | 194.5M |
| Revenue Surprise | -10.81% |
| Release date | Aug 05, 2025 |
| EPS estimate | -$0.81 |
| EPS actual | -$0.600 |
| EPS Surprise | 25.93% |
| Revenue estimate | 183.975M |
| Revenue actual | 164.1M |
| Revenue Surprise | -10.80% |
Last 4 Quarters for Lemonade
Below you can see how LMND performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 05, 2025 |
| Price on release | $47.93 |
| EPS estimate | -$0.81 |
| EPS actual | -$0.600 |
| EPS surprise | 25.93% |
| Date | Price |
|---|---|
| Jul 30, 2025 | $36.28 |
| Jul 31, 2025 | $37.68 |
| Aug 01, 2025 | $36.40 |
| Aug 04, 2025 | $37.00 |
| Aug 05, 2025 | $47.93 |
| Aug 06, 2025 | $51.07 |
| Aug 07, 2025 | $47.26 |
| Aug 08, 2025 | $48.98 |
| Aug 11, 2025 | $52.37 |
| 4 days before | 32.11% |
| 4 days after | 9.26% |
| On release day | 6.55% |
| Change in period | 44.35% |
| Release date | Nov 05, 2025 |
| Price on release | $78.73 |
| EPS estimate | -$0.720 |
| EPS actual | -$0.510 |
| EPS surprise | 29.17% |
| Date | Price |
|---|---|
| Oct 30, 2025 | $59.01 |
| Oct 31, 2025 | $60.08 |
| Nov 03, 2025 | $61.54 |
| Nov 04, 2025 | $58.66 |
| Nov 05, 2025 | $78.73 |
| Nov 06, 2025 | $75.13 |
| Nov 07, 2025 | $75.02 |
| Nov 10, 2025 | $78.89 |
| Nov 11, 2025 | $79.14 |
| 4 days before | 33.42% |
| 4 days after | 0.521% |
| On release day | -4.57% |
| Change in period | 34.11% |
| Release date | Feb 19, 2026 |
| Price on release | $61.67 |
| EPS estimate | -$0.410 |
| EPS actual | -$0.290 |
| EPS surprise | 29.27% |
| Date | Price |
|---|---|
| Feb 12, 2026 | $61.96 |
| Feb 13, 2026 | $63.76 |
| Feb 17, 2026 | $64.59 |
| Feb 18, 2026 | $65.73 |
| Feb 19, 2026 | $61.67 |
| Feb 20, 2026 | $57.31 |
| Feb 23, 2026 | $50.51 |
| Feb 24, 2026 | $52.22 |
| Feb 25, 2026 | $51.85 |
| 4 days before | -0.468% |
| 4 days after | -15.92% |
| On release day | -7.07% |
| Change in period | -16.32% |
| Release date | Apr 29, 2026 |
| Price on release | $56.00 |
| EPS estimate | -$0.580 |
| EPS actual | -$0.470 |
| EPS surprise | 18.97% |
| Date | Price |
|---|---|
| Apr 23, 2026 | $66.14 |
| Apr 24, 2026 | $65.71 |
| Apr 27, 2026 | $65.60 |
| Apr 28, 2026 | $65.77 |
| Apr 29, 2026 | $56.00 |
| Apr 30, 2026 | $56.64 |
| May 01, 2026 | $56.66 |
| May 04, 2026 | $55.05 |
| May 05, 2026 | $57.17 |
| 4 days before | -15.33% |
| 4 days after | 2.09% |
| On release day | 1.14% |
| Change in period | -13.56% |
Lemonade Earnings Call Transcript Summary of Q1 2026
Key investor takeaways from Lemonade's Q1 2026 earnings call: 1) Strong top-line acceleration — in-force premium (IFP) reached $1.33B, up 32% YoY, and revenue rose 71% YoY (to $258M) driven in part by a reinsurance transition that increased premium retention. 2) Rapid improvement in profitability — gross profit grew 159% to $100M, adjusted gross margin (using revenue) was 39%, adjusted EBITDA loss narrowed 64% YoY to a $17M loss, and adjusted free cash flow was positive $17M (fourth consecutive quarter positive). Management reiterated expectation for a fully EBITDA-positive quarter in Q4 2026 and a positive full year in 2027. 3) Product and distribution momentum — Pet insurance is now the largest product line and hit $500M IFP; cross-sell/bundling is increasing (18% of IFP bundled) and is largely CAC-free, supporting durable LTV improvement. 4) AI / operational moat — management emphasizes a decade of integrated AI, data, and regulatory execution that they view as a sustainable competitive advantage; LTV to CAC remains above 3x despite materially higher marketing spend. 5) Expense and capital notes — operating expenses (ex-LLAE) rose 25% YoY as growth and discretionary investments continued; full-year gross marketing spend guided to ~$235M; expected stock‑based comp for 2026 about $95M (up due to multi‑year founder grants). 6) Reinsurance and risk items — reinsurance retention is phasing in (seed retention ~30% in Q1, expected to normalize to ~20% after July renewal unless terms change); Q1 included ~5% cat impact (winter storms) and favorable prior-period development. 7) Other investor-relevant items — annual dollar retention (ADR) held at ~85% (impacted by deliberate homeowners clean-the-book actions that should fade), modest headcount growth (≈2% YoY to 1,291), and ample liquidity (~$1.1B cash & investments, ~$290M regulatory surplus). Risks called out: reinsurance renewal uncertainty, short-term ADR headwinds from home nonrenewals, and seasonality in operating cash flow.
Sign In
Buy LMND